FAIRE UN DON
ADHERER

News

AMCCNews
Retinoblastoma AMCC

Meeting of French-speaking ophthalmologists and ocularists – Kinshasa – December 1, 2022

On December 1, 2022, a meeting was held in Kinshasa for all French-speaking ophthalmologists and ocularists involved in the AMCC retinoblastoma program.

This meeting took place at the Hôtel du Fleuve in Kinshasa, Democratic Republic of Congo, just before the start of the SAFO (Société Africaine Francophone d’Ophtalmologie) congress.

During this meeting, we discussed the current situation regarding ocular prostheses. Under the supervision of our prosthetist Allison Louvet from Paris, the prosthetists gathered at the university clinics, where they worked on Thursday and Friday and made prostheses for several children.

We then discussed the involvement of ophthalmologists in the successful and effective treatment of retinoblastoma, the research protocol planned for 2023 on a prospective study into the reasons for late diagnosis of retinoblastoma, the organization of post-treatment monitoring, life after retinoblastoma with testimonials from children who have been cured, early diagnosis actions and programs, data recording in Redcap, and finally conservative treatment and participation in web conferences.

Short videos were recorded of ophthalmologists talking about the early signs of retinoblastoma, which were then shared on social media in different countries.

On Friday, we presented a symposium on retinoblastoma to all SAFO ophthalmologists.

Thanks to Karim Assani and Pierre Bey for organizing this meeting, and to all participants for their active presence and involvement.

Karim Assani, Jenny Yanga, and I then went to Lubumbashi.

On Monday morning, December 5, we met with Professor Gaby Chenge and Dr. Sandra Iye in the operating room of the Lubumbashi University Clinics and were able to examine three children under general anesthesia. One of the children underwent laser treatment for retinoblastoma, which is currently being treated. The cryode was almost operational, but the connection tip needs to be replaced. Thus, the first conservative treatment of retinoblastoma in the Democratic Republic of Congo was performed on December 5, 2022, at the Lubumbashi University Clinics.

Thank you to the entire ophthalmology team and the anesthesiologists.

Pathology AMCC

Dakar Medical Days, Cheikh Anta Diop University, Dakar

As part of the 19th Dakar Medical, Pharmaceutical, Dental, and Veterinary Conference, which will be held from April 26 to 29, 2023, at Cheikh Anta Diop University, a symposium on childhood cancers will be held on Friday, April 28. The following topics will be presented: the Reference Center for Child Diagnosis (CRDCE), the immunophenotypic aspects of leukemia and solid tumors, carcinogenesis data, and immunotherapy in childhood cancers.

These presentations address the biological and anatomo-pathological aspects of CRDCE in conjunction with the Pediatric Oncology Unit in Dakar and correspond to the implementation of the CRDCE project created with the support of the Sanofi Espoir Foundation through the My Child Matters program and with the current support of the Sanofi Foundation S.

This entire project is the result of the efforts of hematologists, cytogeneticists, pathologists, and pediatric oncologists in Dakar, with support from the AMCC as part of the Pathology and Diagnostic Support program.

Retinoblastoma AMCC

ISOO Africa 2023

From August 21 to 23, 2023, the first ISOO congress on African soil was held in Mombasa, Kenya.

This conference, organized by Didi Fabian, Kahaki Kimani, and Laurence Desjardins, enabled many African ophthalmologists and pediatric oncologists to present the current state of retinoblastoma care and discuss current treatments with colleagues from the ISOO.

The event was a huge success, with more than 30 African countries participating, thanks to the support of the AMCC, Saint Jude, Retinostop, the Eye Cancer Foundation, Sheba Global, the Aslan Project, Know the Glow, One Retinoblastoma World, etc.

You can view the proceedings of this conference by clicking on ISOO Africa 2023.

Pain palliative care AMCC

2023 Palliative Care Programme – AMCC

Mission 2023

Improving the quality of life of people suffering from serious, potentially fatal illnesses is a new concept in French-speaking Africa and is a major concern for the "Alliance Mondiale Contre le Cancer" (AMCC), which has been working for years on the theme of "pain and palliative care" through several training initiatives in different countries in the sub-region, in partnership with Hospice Africa Uganda and its French branch, Hospice Africa France. In Benin, more than 70,000 people are thought to need palliative care each year due to cancer, AIDS and other non-communicable diseases (NCDs). The AMCC's palliative care and pain management programme is back on track after a period of uncertainty linked to the Covid pandemic. The team in charge of this programme organised a mission to Benin from 8 to 19 September 2023.

For more information: AMCC 2023 mission report

Pathology AMCC

The dynamism of the Reference Center for the Diagnosis of Childhood Cancers (CRDCE)

The CRDCE in Dakar, Senegal, was present at two important virtual conferences: the AORTIC/OAREC (African Organization for Research and Training in Cancer) conference from November 5 to 10, 2021, and the London Global Cancer Week (LGCW) conference, which is being held from November 14 to 19, 2021.

The CRDCE's activities were presented, including the implementation of improvements for reliable and timely diagnosis and the installation of complementary techniques for characterizing tumor cells using immunohistochemistry or flow cytometry.

Classical and molecular cytogenetic techniques, as well as molecular biology, will soon be available to characterize childhood cancers.

All the techniques required for accurate and reliable diagnosis will therefore be put in place in Dakar, reflecting the dynamism of the entire local team with the support of the Sanofi Espoir Foundation as part of the "My Child Matters" program.

MENU